Not applicableStudy completedNCT06460324
What this trial is testing
Assess COVID-19 Vaccination Immune Response in Multiple Sclerosis Patients Treated With Ofatumumab
Who this might be right for
Multiple Sclerosis
Novartis Pharmaceuticals 38
Showing 20 of 0 results